| Financial Year |
March 31 2023 |
| Monetary Funds |
1,173,820,565.70 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
358,836.49 |
| Accounts Receivable |
354,125,425.53 |
| Advances to Suppliers |
365,396,201.81 |
| Other Receivables |
59,585,296.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
946,594,879.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,682,017.98 |
| Other Current Assets |
16,023,504.59 |
| Total Current Assets |
3,026,581,989.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
57,599,253.49 |
| Long-term Equity Investment |
15,910,875.94 |
| Investment Properties |
-- |
| Fixed Assetes |
719,134,284.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,689,278,234.54 |
| R&D expenses |
-- |
| Goodwill |
208,370,209.04 |
| Long-Term Deferred and Prepaid Expenses |
975,667.93 |
| Deferred Income Tax Assets |
30,950,271.19 |
| Other Non-Current Assets |
3,236,749.37 |
| Sub-Total of Non-Current Assets |
2,729,162,932.15 |
| Total Assets |
5,755,744,921.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
735,520,356.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,574,673.88 |
| Taxes Payable |
93,052,554.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
96,630,319.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,487,731.46 |
| Other Current Liabilities |
16,485,292.71 |
| Sub-Total of Current Liabilities |
1,375,321,780.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,773,657.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,366,209.26 |
| Total Liabilities |
1,404,687,990.10 |
| Paid-In Capital(Or Share Stock) |
500,048,597.00 |
| Capital Surplus |
1,809,680,936.62 |
| Surplus Reserve |
142,938,037.71 |
| LESS:Treasury Stock |
50,824,906.85 |
| Undistributed Profits |
1,802,917,390.44 |
| Minority Stockholder's Interest |
68,770,071.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,282,286,860.53 |
| Owner's Equity（Stockholder's Equity） |
4,351,056,931.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,755,744,921.93 |
